Advanced search
Publication Cover
Autoimmunity Volume 35, 2002 - Issue 5
Submit an article Journal homepage
28
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Autoimmune Hepatitis: The Way We Were, the Way We Are Today and the Way We Hope to Be

Ian R. Mackaya Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic. 3800, Australia
&
Ban-Hock Tohb Department of Pathology and Immunology, Monash University, Prahran, Vic. 3181, Australia
Pages 293-305 | Published online: 07 Jul 2009

  • Krawitt, E.L. (1996) "Autoimmune hepatitis", New Engl. J. Med. 334, 897 - 903
  • Obermayer-Straub, P., Strassburg, C.P. and Manns, M.P. (2000) "Autoimmune hepatitis", J. Hepatol. 32, 181 - 197
  • Czaja, A.J. (2001) "Understanding the pathogenesis of autoimmune hepatitis", Am. J. Gastroenterol. 96, 1224 - 1231
  • Manns, M.P. and Strassburg, C.P. (2001) "Autoimmune hepatitis: clinical challenges", Gastroenterology 120, 1502 - 1517
  • Kita, H., Mackay, I.R., Van de Water, J. and Gershwin, M.E. (2001) "The lymphoid liver: considerations on pathways to autoimmune injury", Gastroenterology 190, 1485 - 1501
  • Barker, M.H., Capps, R.B. and Allen, F.W. (1945) "Chronic hepatitis in the Mediterranean theater: a new clinical syndrome", J. Am. Med. Assoc. 129, 653 - 659
  • Capps, R.B. (1948) "Clinical aspects of the sequelae of acute hepatitis", Gastroenterology 11, 680 - 684
  • Waldenström, J. (1950) "Leber, Blutproteine und Nahrungseiweiss", Dtsch. Z. Verdau Stoffwechselkrankh 2, 113 - 119
  • Bearn, A.G., Kunkel, H.G. and Slater, R. (1956) "The problem of chronic liver disease in young women", Am. J. Med. 21, 3 - 15
  • Kunkel, H.G., Ahrens, Jr., E.H., Eisenmenger, W.J., et al., (1951) "Extreme hypergammaglobulinaemia in young women with liver disease of unknown etiology (abstract)", J. Clin. Investig. 30, 654
  • Wood, I.J., King, W.E., Parsons, P.J., et al., (1948) "Non-suppurative hepatitis: a study of acute and chronic forms with special reference to biochemical and histological changes", Med. J. Aust. 11, 249 - 261
  • Hargraves, M.M., Richmond, H. and Morton, R.J. (1948) "Presentation of two bone marrow elements: the"tart"cell and the"L.E."cell", Proc. Mayo Clin. 23, 25 - 28
  • Joske, R.A. and King, W.E. (1965) "The L.E. cell phenomenon in active chronic viral hepatitis", Lancet 2, 878 - 879
  • Mackay, I.R., Taft, L.I. and Cowling, D.C. (1956) "Lupoid hepatitis", Lancet 2, 1323 - 1326
  • Mackay, I.R. and Gajdusek, D.C. (1958) "An 'autoimmune' reaction against human tissue antigens in certain acute and chronic diseases: II. Clinical correlations", Arch. Intern. Med. 101, 30 - 46
  • Mackay, I.R., Weiden, S. and Hasker, J. (1965) "Autoimmune hepatitis", Ann. NY Acad. Sci. 24, 767 - 780
  • Friou, C.J. (1957) "Clinical application of lupus serum nucleoprotein reaction using fluorescent antibody technique", J. Clin. Investig. 36, 890 - 897
  • Holborow, E.J., Asherson, G.L., Johnson, G.D., Barnes, R.D.S. and Carmichael, P.S. (1963) "Antinuclear factor and other antibodies in blood and liver diseases", Br. Med. J. 1, 656 - 658
  • Johnson, G.D., Holborow, E.J. and Glynn, L.E. (1965) "Antibody to smooth muscle in patients with liver disease", Lancet 2, 878 - 879
  • Whittingham, S., Mackay, I.R. and Irwin, J. (1966) "Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells", Lancet 1, 1333 - 1335
  • Rizzetto, M., Swana, G. and Doniach, D. (1973) "Microsomal antibodies in active chronic hepatitis and other disorders", Clin. Exp. Immunol. 15, 331 - 344
  • Mackay, I.R. and Morris, P.J. (1972) "Association of autoimmune chronic hepatitis with HLA1,8", Lancet ii, 793 - 795
  • Mackay, I.R. and Tait, B.D. (1980) "HLA associations with autoimmune type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies", Gastroenterology 79, 95 - 98
  • Donaldson, P.T., Doherty, D.G., Hayllar, K.M., et al., (1991) "Susceptibility to autoimmune chronic active hepatitis: human leucocyte antigens DR4 and A1-B8-DR3 are independent risk factors", Hepatology 13, 701 - 706
  • Mackay, I.R. (1972) "The prognoses of chronic hepatitis", Ann. Intern. Med. 77, 649 - 651
  • Blumberg, B.S., Gerstley, B.J.S., Hungerford, D.A., et al., (1967) "A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis", Ann. Intern. Med. 66, 927 - 931
  • Sutnick, A.I., London, W.T. and Blumberg, B.S. (1971) "Australia antigen: a genetic basis for chronic liver disease and hepatoma?", Ann. Intern. Med. 74, 442 - 444
  • Choo, Q.L., Kuo, G., Weiner, A.J., et al., (1989) "Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome", Science 244, 359 - 362
  • Mackay, I.R. (2000) "Science, medicine and the future: tolerance and autoimmunity", Brit. Med. J. 321, 93 - 96
  • Bjarnason, I., Magnusson, B. and Bjornsson, S. (1982) "Idiopathic chronic active hepatitis in Iceland", Acta Med. Scand. 211, 305 - 307
  • Toda, G., Zeniya, M., Watanabe, F., et al., and the Japanese National Study Group of Autoimmune Hepatitis (1997) "Present status of autoimmune hepatitis in Japan -- correlating the characteristics with International criteria in an area with a high rate of HCV infection", J. Hepatol. 26, 1207 - 1212
  • Boberg, K.M., Aaland, E., Jahnsen, J., Raknerud, N., Stiris, M. and Bell, H. (1998) "Incidence and prevalance of autoimmune hepatitis in a Norwegian population", Scand. J. Gastroenterol. 33, 99 - 103
  • Popper, H., Paronetto, F. and Schaffner, F. (1965) "Immune processes in the pathogenesis of liver disease", Ann. NY Acad. Sci. 124, 781 - 799
  • Page, A.R. and Good, R.A. (1960) "Plasma cell hepatitis with special attention to steroid therapy", Am. J. Dis. Child. 99, 288 - 314
  • Searle, J., Harmon, B.V., Bishop, C.J. and Kerr, J.F.R. (1987) "Significance of single cell death by apoptosis in hepatobiliary disease", J. Gastroenterol. Hepatol. 2, 77 - 96
  • O'Brien, E.N., Goble, A.J. and Mackay, I.R. (1958) "Plasma transaminase activity as an index of the effectiveness of cortisone in chronic hepatitis", Lancet i, 1245 - 1249
  • Mackay, I.R., Weiden, S. and Ungar, B. (1964) "The treatment of active chronic and lupoid hepatitis with 6-mercaptopurine and azathioprine", Lancet 1, 899-902.
  • Mackay, I.R. (1968) "Chronic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone", Quart. J. Med. 37, 379-392.
  • Cook, G.C., Mulligan, R. and Sherlock, S. (1971) "Controlled prospective trial of corticosteroid therapy in active chronic hepatitis", Quart. J. Med. 40, 159 - 185
  • Czaja, A.J. (1986) "Autoimmune chronic active hepatitis", In: Czaja, A.J. and Dickson, E.R., eds, Chronic Active Hepatitis. The Mayo Experience (Decker, New York), pp 105 - 126
  • Parker, D.R. and Kingham, J.G.C. (1997) "Type 1 autoimmune hepatitis is primarily a disease of later life", Quart. J. Med. 90, 289 - 296
  • Homberg, J.C., Abuaf, N., Bernard, O., et al., (1987) "Chronic active hepatitis associated with anti-liver kidney microsomal antibody type 1: a second type of 'autoimmune hepatitis'", Hepatology 197, 1333 - 1339
  • Vento, S., Cainelli, F., Renzini, C. and Concia, E. (1997) "Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance", Lancet 350, 1298 - 1299
  • Alvarez, F., Berg, P.A., Bianchi, F.B., et al., (1999) "International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis", J. Hepatol. 31, 929 - 938
  • Mackay, I.R. (2000) "Autoimmune disease overlaps and the liver: Two for the price of one?", J. Gastroenterol. Hepatol. 15, 3 - 8
  • Lohse, A.W., Meyer zum Büschenfelde, K.-H., Franz, B., et al., (1999) "Characterization of the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals", Hepatology 29, 1078 - 1084
  • Kinoshita, H., Omagari, K., Whittingham, S., et al., (1999) "Autoimmune cholangitis and primary biliary cirrhosis: an autoimmune enigma", Liver 14, 122 - 128
  • Czaja, A.J., Carpenter, H.A., Santrach, P.J. and Moore, S.B. (2000) "Autoimmune cholangitis within the spectrum of autoimmune liver disease", Hepatology 31, 1231 - 1238
  • Boberg, K.M., Faiusa, O., Haaland, T., et al., (1996) "Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitits", Hepatology 23, 1369 - 1376
  • Van Buurren, H.R., van Hoogstraten, H.J.E., Terkivatan, T., et al., (2000) "High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis", J. Hepatol. 33, 543 - 548
  • Gregorio, G.V., Portmann, B., Karani, J., et al., (2001) "Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study", Hepatology 33, 544 - 553
  • Park, S.Z., Nagorney, D.M. and Czaja, A.J. (2000) "Hepatocellular carcinoma in autoimmune hepatitis", Dig. Dis. Sci. 45, 1944 - 1948
  • Mackay, I.R. (2001) "Antinuclear (chromatin) autoantibodies in autoimmune hepatitis", J. Gastroenterol. Hepatol. 16, 245 - 247
  • Toh, B.H. (1979) "Smooth muscle autoantibodies and autoantigens", Clin. Exp. Immunol. 38, 621 - 628
  • Toh, B.H. (1991) "Anti-cytoskeletal autoantibodies", Autoimmunity 11, 119 - 125
  • Cancado, E.L.R., Vilas-Boas, L.S., Abrantes-Lemos, C.P., et al., (1996) "Heat serum inactivation as a mandatory procedure for antiactin antibody detection in cell culture", Hepatology 23, 1098 - 1104
  • Lindgren, S., Nilsson, S., Nässberger, L., et al., (2000) "Antineutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalance, antigen specificity and predictive value for diagnosis of autoimmune liver disease", J. Gastroenterol. Hepatol. 15, 437 - 442
  • Terjung, B., Spengler, U., Sauerbruch, T. and Worman, H.J. (2000) "'Atypical p-ANCA' in IBD and hepatobiliary disorders react with a 50 kDa nuclear envelope protein of neutrophils and myeloid cell lines", Gastroenterology 119, 310 - 322
  • Sobajima, J., Ozaki, S., Vesugi, H., et al., (1999) "High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis", Gut 44, 867 - 873
  • Treichel, U., McFarlane, B., Seki, T., et al., (1994) "Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis", Gastroenterology 107, 799 - 804
  • Berg, P.A., Stechemesser, E., Strienz, J., et al., (1981) "Hypergammaglobulinämische chronisch aktive Hepatitis mit Nachweis von leber-pankreas-spezifischen komplemtbindenden Autoantikörpern", Virh Dtsh Ges Inn Med. 87, 921 - 927
  • Manns, M., Gerken, G., Kyriastsoulis, A., et al., (1987) "Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen", Lancet 1, 292 - 294
  • Waechter, B., Kyriatsoulis, A., Lohse, A.W., et al., (1990) "Characterisation of liver cytokeratin as a major target antigen in autoimmune hepatitis", Hepatology 11, 232 - 239
  • Wesierska-Gadek, J., Grimm, R., Hitchman, E., et al., (1998) "Members of the glutathione S -transferase gene family are antigens in autoimmune hepatitis", Gastroenterology 114, 329 - 335
  • Wies, I., Brunner, S., Henninger, J., et al., (2000) "Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis", Lancet 355, 1510 - 1515
  • Volkmann, M., Baurle, M.L., Strassburg, C.P., et al., (2001) "Soluble liver antigen: isolation of a 35 kd recombinant protein (SLA-p35) specifically recognising sera from patients with autoimmune hepatitis", Hepatology 33, 591 - 596
  • Costa, M., Rodriguez-Sanchez, J.L., Czaja, A.J. and Gelpi, C. (2000) "Isolation and characterisation of cDNA encoding the antigenic protein of the human tRNP (ser)sec complex recognised by autoantibodies from patients with type-1 autoimmune hepatitis", Clin. Exp. Immunol. 121, 364 - 374
  • Manns, M.P. and Obermayer-Straub, P. (1997) "Cytochromes P450 and UDP-glucuronyl transferases: model antigens to study drug-induced, virus-induced and autoimmune liver diseases", Hepatology 26, 1054 - 1066
  • Strassburg, C., Obermayer-Straub, P., Duraxxo, A.B., Rizzetto, M., Tukey, R.H., et al., (1996) "Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis", Gastroenterology 11, 1582 - 1592
  • Martini, E., Abuaf, N., Cavalli, F., et al., (1988) "Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2", Hepatology 8, 1662 - 1666
  • Lapierre, P., Hajoui, O., Homberg, J.-C. and Alvarez, F. (1999) "Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognised by sera of patients with autoimmune hepatitis", Gastroenterology 116, 643 - 649
  • Pelli, N., Fensom, A.H., Slade, C., et al., (1998) "Argininosuccinate lyase: a new autoantigen in liver disease", Clin. Exp. Immunol. 114, 455 - 461
  • Fraser, I.H., Jordan, T.W., Collins, E.C., Andrews, P. and Mackay, I.R. (1987) "Antibody to liver membrane antigens in chronic active hepatitis", Hepatology 7, 4 - 10
  • Swanson, N.R., Reed, W.D., Yarred, L.J., Shilkin, K.B. and Joske, R.A. (1990) "Autoantibodies, to isolated plasma membranes in chronic active hepatitis II specificity of autoantibodies", Hepatology 11, 613 - 621
  • Matsuo, I., Ikuno, N., Omagari, K., et al., (2000) "Autoimmune reactivity of sera to hepatocyte plasma membrane in type 1 autoimmune hepatitis", J. Gastroenterol. 35, 226 - 234
  • Tuomi, T., Rowley, M.J., Knowles, W.J., et al., (1994) "Autoantigenic properties of native and denatured qlutamic acid decarboxlyse: evidence for a conformational epitope", Clin. Immunol. Immunopathol. 71, 53 - 59
  • Muratori, L., Parola, M., Ripati, A., et al., (2000) "Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane", Gut 46, 553 - 561
  • Robin, M.A., Le Roy, M., Descatoire, V. and Pessayre, D. (1997) "Plasma membrane cytochromes p450 as neoantigens and autoimmune targets in drug induced hepatitis", J. Hepatol. 26 (Suppl. 1), 23 - 30
  • Lohr, H., Manns, M., Kyriatsoulis, A., et al., (1991) "Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody positive autoimmune chronic active hepatitis", Clin. Exp. Immunol. 84, 297 - 302
  • Nishioji, K., Okanoue, Y., Itoh, S., et al., (2001) "Increase in serum chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase in its mRNA expression in hepatocytes", Clin. Exp. Immunol. 123, 271 - 279
  • Czaja, A.J. and Donaldson, P.T. (2000) "Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis", Immunol. Rev. 174, 250 - 259
  • Tait, B.D., Mackay, I.R., Board, P., et al., (1989) "HLA A1, B8, DR3 extended haplotype in autoimmune chronic hepatitis", Gastroenterology 97, 479 - 481
  • Scully, L.J., Toze, C., Sengar, D.P.S. and Goldstein, R. (1993) "Early-onset autoimmune hepatitis is associated with a C4A gene deletion", Gastroenterology 104, 1478 - 1484
  • Goldberg, A.C., Bittencourt, P.L., Mougin, B., et al., (2001) "Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus", Human Immunol. 62, 165 - 169
  • Gregersen, P.K., Silver, J. and Winchester, R.J. (1987) "The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis", Arthritis Rheum. 30, 1205 - 1213
  • Agarwal, K., Czaja, A.J., Jones, D.E. and Donaldson, P.T. (2000) "Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis", Hepatology 31, 49 - 53
  • Vogel, A., Liermann, H., Harms, A., et al., (2001) "Autoimmune regulator AIRE: Evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome Type 1", Hepatology 33, 1047 - 1052
  • Steven, M.M., Buckley, J.D. and Mackay, I.R. (1979) "Pregnancy in chronic active hepatitis", Quart. J. Med. 48, 519 - 531
  • Henegan, M.A., Norris, S.M., O'Gready, J.G., et al., (2000) "Management and outcome of pregnancy in autoimmune hepatitis", Gut 48, 97 - 102
  • Gonzalez-Koch, A., Czaja, A.J., Carpenter, H.A., et al., (2001) "Recurrent autoimmune hepatitis after orthotopic liver transplantation", Liver Transp. 7, 302 - 310
  • Meyer zum Buschenfelde, K.-H. (1995) "Autoimmune hepatitis", New Engl. J. Med. 333, 1004 - 1005
  • Yarze, J.C. (1996) "Autoimmune hepatitis", New Engl. J. Med. 334, 923 - 924
  • Czaja, A.J. and Homburger, H.A. (2001) "Autoantibodies in liver disease", Gastroenterology 120, 239 - 249
  • Lohr, H., Treichel, U., Poralla, T., et al., (1990) "The human asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis", Hepatology 12, 1314 - 1320
  • Lohr, H.R., Schlaak, J.F., Lohse, A.W., et al., (1996) "Autoreactive CD4+ LKM-specific and anticlonotypic T cell responses in LKM-1 antibody-positive autoimmune hepatitis", Hepatology 24, 1416 - 1421
  • Arenz, M., Pingel, S., Schirmacher, P., et al., (2001) "T cell receptor V beta chain restriction and preferred CDR3 motifs of liver-kidney microsomal antigen (LKM-1)-reactive T cells from autoimmune hepatitis patients", Liver 21, 18 - 25
  • Hickling, J. (1998) "Measuring human T-lymphocyte function", Exp. Rev. Mol. Med. http://www.ermm.cbcu.cam.ac.uk/jhc/txt001jhc.htm
  • Mehal, W.Z., Azzaroli, F. and Crispe, N. (2001) "Immunology of the healthy liver: old questions and new insights", Gastroenterology 120, 250 - 260
  • Karanikas, V., Mackay, I.R., Rowley, M.J., et al., (1995) "Hepatic portal infiltrates in mice immunized with syngeneic lymphoid cells: connotations for models of autoimmune liver disease", J. Gastroenterol. Hepatol. 10, 491 - 497
  • Toh, B.H., Sentry, J. and Alderuccio, F. (2000) "The causative H/K ATPase antigen in the pathogenesis of autoimmune gastritis", Immunol. Today 21, 352 - 358
  • Myozaki, M., Kamiyasu, M., Miura, T., et al., (1996) "Induction of autoimmune hepatitis and autoantibodies to liver antigens by neonatal thymectomy in mice", Clin. Exp. Immunol. 104, 133 - 143
  • Stanley, N.F., Leak, P.J., Walters, M.N.-I. and Joske, R.A. (1964) "Murine infection with reovirus: the chronic disease following reovirus type 3 infection", Brit. J. Exp. Path. 45, 142 - 149
  • Walters, M.N.-I., Stanley, N.F., Dawkins, R.L., et al., (1973) "Immunological assessment of mice with chronic jaundice and runting induced by reovirus 3", Brit. J. Exp. Path. 54, 329 - 345
  • Bhathal, P.S., Rose, N.R., Mackay, I.R. and Whittingham, S. (1983) "Genetics of carbon tetrachloride induced liver injury in mice. I Histological and functional studies", Brit. J. Exp. Pathol. 64, 524 - 533
  • Hardy, C.L., Bhathal, P.S., Snibson, K.J. and Adams, T.E. (1997) "Comparison of intrahepatic lymphocytes from normal and growth hormone transgenic mice with chronic hepatitis and liver cancer", Immunology 90, 412 - 420
  • Wolf, D., Hallman, R., Sass, G., et al., (2001) "TNFα-induced expression of adhesion molecules in the liver is under the control of TNFR1 -- relevance for concanavalin A induced hepatitis", J. Immunol. 166, 1300 - 1307
  • Chen, D., McKallip, R.N., Zeytun, A., et al., (2001) "CD44-deficient mice exhibit enhanced hepatitis after concanavalin injection: evidence for involvement of CD44 in activation induced cell death", J. Immunol. 166, 5889 - 5897
  • Coyle, A.J. and Guterrez-Ramos, J.G. (2001) "The expanding B-7 superfamily: increasing complexify in costimulatory signals regulating T cell function", Nature Immunol. 2, 203 - 209
  • Budd, R.C. (2001) "Activation-induced cell death", Curr. Opin. Immunol. 13, 356 - 362
  • Shevach, E.M. (2001) "Certified professionals: CD4(+)CD25(+) suppressor T cells", J. Exp. Med. 193, F41 - F46
  • Goodnow, G.C. (2001) "Pathways for self tolerance and the treatment of autoimmune diseases", Lancet 357, 2115 - 2121
  • Marrack, P., Kappler, J. and Kotzin, B.L. (2001) "Autoimmune disease: why and where it occurs," Nature Med., 7, 899-905.
  • Davidson, A. and Diamond, B. (2001) "Autoimmune diseases", New Engl. J. Med. 345, 340 - 350
  • Garcia-Buey, L., Garcia-Monzon, C., Rodriguez, S., et al., (1995) "Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C", Gastroenterology 108, 142 - 149
  • Bosi, E., Minelli, R., Bazzigaluppi, E. and Salvi, M. (2001) "Fulminant autoimmune Type 1 diabetes during interferon-alpha theraphy: a case of Th1-mediated disease?", Diabet. Med. 18, 329 - 332
  • Charles, P.J., Smeenk, R.J.T., DeJong, J., Feldman, M. and Maini, R.N. (2000) "Assessment of antibodies to ds DNA induced in rheumatoid arthritis (RA) patients following treatment with infliximab, a monodonal antibody to TNF alpha", Arthritis Rheum. 43, 2383 - 2390
  • Mackay, I.R. and Rose, N.R. (1998) "Autoimmunity yesterday, today and tomorrow", In: Rose, N.R. and Mackay, I.R., eds, The Autoimmune Diseases (Academic Press, San Diego), p 868

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.